Cargando…

Safety and T Cell Modulating Effects of High Dose Vitamin D(3) Supplementation in Multiple Sclerosis

BACKGROUND: A poor vitamin D status has been associated with a high disease activity of multiple sclerosis (MS). Recently, we described associations between vitamin D status and peripheral T cell characteristics in relapsing remitting MS (RRMS) patients. In the present study, we studied the effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smolders, Joost, Peelen, Evelyn, Thewissen, Mariëlle, Cohen Tervaert, Jan Willem, Menheere, Paul, Hupperts, Raymond, Damoiseaux, Jan
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001453/ https://www.ncbi.nlm.nih.gov/pubmed/21179201 http://dx.doi.org/10.1371/journal.pone.0015235

Ejemplares similares

Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2009)

Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis
por: Mimpen, Max, et al.
Publicado: (2021)

Stress-Axis Regulation by Vitamin D(3) in Multiple Sclerosis
por: Rolf, Linda, et al.
Publicado: (2018)

Exploring the effect of vitamin D(3) supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis
por: Rolf, Linda, et al.
Publicado: (2017)

T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?
por: Wilde, Benjamin, et al.
Publicado: (2010)

Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy
por: Wilde, Benjamin, et al.
Publicado: (2012)

Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up
por: Muris, Anne-Hilde, et al.
Publicado: (2016)

Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
por: Mimpen, Max, et al.
Publicado: (2020)

The Engagement Between Vitamin D and the Immune System: Is Consolidation by a Marriage to Be Expected?
por: Damoiseaux, Jan, et al.
Publicado: (2018)

Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions
por: Muris, Anne-Hilde, et al.
Publicado: (2014)

Vitamin D and Multiple Sclerosis: Correlation, Causality, and Controversy
por: Smolders, Joost
Publicado: (2010)

Automatic Reading of ANCA-Slides: Evaluation of the AKLIDES System
por: Damoiseaux, Jan, et al.
Publicado: (2012)

Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon β-1a
por: Hupperts, Raymond, et al.
Publicado: (2019)

Patients with non-relapsing ANCA-associated vasculitis have increased numbers of circulating IL-10 producing Th17 cells
por: Wilde, B, et al.
Publicado: (2010)

Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study
por: Slot, Marjan C, et al.
Publicado: (2006)

An Update on Vitamin D and Disease Activity in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2019)

CD45RC Isoform Expression Identifies Functionally Distinct T Cell Subsets Differentially Distributed between Healthy Individuals and AAV Patients
por: Ordonez, Laurence, et al.
Publicado: (2009)

High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial
por: Dörr, Jan, et al.
Publicado: (2020)

Methods of Assessing Nailfold Capillaroscopy Compared to Video Capillaroscopy in Patients with Systemic Sclerosis—A Critical Review of the Literature
por: Ma, Zechen, et al.
Publicado: (2023)

Evaluating the safety of β-interferons in MS: A series of nested case-control studies
por: de Jong, Hilda J.I., et al.
Publicado: (2017)

Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literature
por: Colaris, Maartje J. L., et al.
Publicado: (2017)

Evidence of a Novel Mitochondrial Signature in Systemic Sclerosis Patients with Chronic Fatigue Syndrome
por: van Eeden, Charmaine, et al.
Publicado: (2023)

Vitamin D/CD46 Crosstalk in Human T Cells in Multiple Sclerosis
por: Killick, Justin, et al.
Publicado: (2020)

Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?
por: Osman, Mohammed S., et al.
Publicado: (2020)

Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
por: Kemna, Michael J., et al.
Publicado: (2017)

CD4(+)CD28(null) T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis
por: Slot, Marjan C., et al.
Publicado: (2017)

The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells
por: Berge, T, et al.
Publicado: (2016)

Impact of Vitamin D Supplementation on Multiple Sclerosis
por: Gandhi, Fenil, et al.
Publicado: (2021)

Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis
por: Chu, Raymond, et al.
Publicado: (2021)

Natural Killer Cell Dysfunction and Its Role in COVID-19
por: van Eeden, Charmaine, et al.
Publicado: (2020)

COVID-19, rheumatic diseases and immune dysregulation—a perspective
por: Tariq, Shahna, et al.
Publicado: (2021)

Editorial: Vitamin D in Neurological Diseases: From Pathophysiology to Therapy
por: Smolders, Joost, et al.
Publicado: (2021)

Programmed Cell Death Protein 1–Positive CD8(+) T Cells in Multiple Sclerosis: Exhausted Fighters or Peacekeepers
por: Smolders, Joost, et al.
Publicado: (2022)

Editorial: Environmental factors influencing the immune functions during multiple sclerosis
por: Smolders, Joost, et al.
Publicado: (2023)

B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions
por: Claes, Nele, et al.
Publicado: (2015)

The IL-2 – IL-2 receptor pathway: Key to understanding multiple sclerosis
por: Peerlings, Daphne, et al.
Publicado: (2021)

Staphylococcus aureus and Wegener's granulomatosis
por: Popa, Eliane R, et al.
Publicado: (2002)

Cutaneous adverse events associated with long-term immunomodulating therapy in multiple sclerosis
por: Balak, Deepak MW, et al.
Publicado: (2011)

High-dose vitamin D(3) supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial
por: Cassard, Sandra D., et al.
Publicado: (2023)

DNA extraction from long-term stored urine
por: Hilhorst, Marc, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hkandsa87v1iqs2fqu1u1luton